BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20610122)

  • 1. Intravenous levetiracetam in the management of acute seizures in children.
    Reiter PD; Huff AD; Knupp KG; Valuck RJ
    Pediatr Neurol; 2010 Aug; 43(2):117-21. PubMed ID: 20610122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of intravenous levetiracetam in acute seizure management of children.
    Kirmani BF; Crisp ED; Kayani S; Rajab H
    Pediatr Neurol; 2009 Jul; 41(1):37-9. PubMed ID: 19520272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous levetiracetam in children with epilepsy.
    Goraya JS; Khurana DS; Valencia I; Melvin JJ; Cruz M; Legido A; Kothare SV
    Pediatr Neurol; 2008 Mar; 38(3):177-80. PubMed ID: 18279751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous levetiracetam in children with seizures: a prospective safety study.
    Ng YT; Hastriter EV; Cardenas JF; Khoury EM; Chapman KE
    J Child Neurol; 2010 May; 25(5):551-5. PubMed ID: 20413804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O; Chang E; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy.
    Depositario-Cabacar DT; Peters JM; Pong AW; Roth J; Rotenberg A; Riviello JJ; Takeoka M
    Epilepsia; 2010 Jul; 51(7):1319-22. PubMed ID: 20163437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B;
    Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjunctive levetiracetam therapy in pediatric intractable epilepsy.
    Lee YJ; Kang HC; Kim HD; Lee JS
    Pediatr Neurol; 2010 Feb; 42(2):86-92. PubMed ID: 20117743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital.
    McTague A; Kneen R; Kumar R; Spinty S; Appleton R
    Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
    Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
    Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of levetiracetam: a review of three pivotal clinical trials.
    Privitera M
    Epilepsia; 2001; 42 Suppl 4():31-5. PubMed ID: 11564123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam for seizures in children with brain tumors and other cancers.
    Partap S; Fisher PG
    Pediatr Blood Cancer; 2009 Feb; 52(2):288-9. PubMed ID: 18831033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid dosage titration of levetiracetam in children.
    Vaisleib II; Neft RA
    Pharmacotherapy; 2008 Mar; 28(3):393-6. PubMed ID: 18294118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of levetiracetam in hospitalized patients.
    Falip M; Carreño M; Amaro S; Donaire A; Delgado R; Toledo M; Maestro I
    Epilepsia; 2006 Dec; 47(12):2186-8. PubMed ID: 17201722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of intravenous levetiracetam for acute seizure management in preterm neonates.
    Khan O; Cipriani C; Wright C; Crisp E; Kirmani B
    Pediatr Neurol; 2013 Nov; 49(5):340-3. PubMed ID: 23921284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of levetiracetam in children with epilepsy younger than 2 years of age.
    Krief P; Li Kan ; Maytal J
    J Child Neurol; 2008 May; 23(5):582-4. PubMed ID: 18448575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability and dosing experience of intravenous levetiracetam in children and infants.
    Michaelides C; Thibert RL; Shapiro MJ; Kinirons P; John T; Manchharam D; Thiele EA
    Epilepsy Res; 2008 Oct; 81(2-3):143-7. PubMed ID: 18571898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
    Li S; Cao J; Xiao N; Cai F
    J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.